SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-23-005997
Filing Date
2023-01-30
Accepted
2023-01-30 16:05:08
Documents
2
Group Members
ZHIJUN XIAO

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D ea171785-13da1feng_china.htm SC 13D/A 90213
2 JOINT FILING AGREEMENT ea171785ex99-1_china.htm EX-99.1 5834
  Complete submission text file 0001213900-23-005997.txt   97364
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Subject) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-90926 | Film No.: 23567736
SIC: 2834 Pharmaceutical Preparations

Mailing Address NO. 35 SECOND GROUP GELIAN VILLAGE LIANGSU TOWN JIANGYAN CITY JIANGSU PROVINCE JIANGYAN F4 225500
Business Address
Zhou Albert Feng (Filed by) CIK: 0001768175 (see all company filings)

Type: SC 13D/A